TrialAntimicrobial agents and chemotherapy2013

Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.

Dominique Larrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.